Multimodal brain network topology and enhanced computer-aided diagnosis in Parkinson’s Disease: a systematic review and meta-analysis - Scorecard - MDSpire
Advertisement
Multimodal brain network topology and enhanced computer-aided diagnosis in Parkinson’s Disease: a systematic review and meta-analysis
Clinical Scorecard: Comprehensive Analysis of Brain Network Structures and Improved Computer-Assisted Diagnosis in Parkinson’s Disease: A Systematic Review and Meta-Analysis
At a Glance
Category
Detail
Condition
Parkinson’s disease (PD), a neurodegenerative disorder characterized by brain network alterations
Key Mechanisms
Disruption of brain network topology including decreased segregation and integration measured by multimodal neuroimaging and graph theoretical analysis
Target Population
Patients diagnosed with Parkinson’s disease across various symptom subtypes including cognitive impairment
Care Setting
Clinical and research settings utilizing neuroimaging and computational diagnostic tools
dMRI shows significant deficits in both network segregation (clustering coefficient, local efficiency) and integration (global efficiency, characteristic path length).
fMRI indicates mainly reduced network segregation with increased modularity; sMRI and EEG show no consistent abnormalities.
Guideline-Based Recommendations
Diagnosis
Use graph theoretical analysis (GTA) metrics derived from multimodal neuroimaging to identify brain network alterations in PD.
Consider combining GTA metrics with computational techniques for automated early diagnosis, pending further validation.
Management
Monitor brain network topology changes to understand disease progression and treatment response.
Recognize distinct symptom subtypes may involve different network alterations influencing management strategies.
Monitoring & Follow-up
Employ longitudinal neuroimaging studies to track global network topology alterations over disease course.
Use multimodal imaging biomarkers to assess treatment efficacy and cognitive impairment progression.
Risks
Current diagnostic methods remain predominantly clinical and may miss atypical or prodromal PD cases.
Inconsistencies across studies and modalities necessitate cautious interpretation of network alteration findings.
Patient & Prescribing Data
3736 PD patients and 2384 healthy controls across 80 studies with multimodal imaging data
Brain network metrics may serve as biomarkers for early diagnosis and monitoring but require further validation before routine clinical use.
Clinical Best Practices
Incorporate multimodal neuroimaging (especially dMRI and fMRI) to assess brain network disruptions in PD patients.
Apply advanced multilevel random-effects meta-analytic models to account for statistical dependencies in research data.
Focus on cognitive impairment subtype for targeted network alteration analysis.
Interpret neuroimaging findings in context of symptom heterogeneity and disease stage.
A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness
